Rosemary Burke

3.8k total citations
24 papers, 579 citations indexed

About

Rosemary Burke is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Rosemary Burke has authored 24 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cell Biology. Recurrent topics in Rosemary Burke's work include Cancer-related Molecular Pathways (6 papers), Protein Degradation and Inhibitors (5 papers) and Microtubule and mitosis dynamics (4 papers). Rosemary Burke is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Protein Degradation and Inhibitors (5 papers) and Microtubule and mitosis dynamics (4 papers). Rosemary Burke collaborates with scholars based in United Kingdom, United States and Australia. Rosemary Burke's co-authors include Craig McAndrew, Paul Workman, Julian Blagg, Ian Collins, Mark Stubbs, Rob L. M. van Montfort, Paul A. Clarke, Keith Jones, Isaac M. Westwood and John Caldwell and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Rosemary Burke

23 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosemary Burke United Kingdom 13 404 112 108 93 71 24 579
Ruth Ruddle United Kingdom 12 409 1.0× 137 1.2× 62 0.6× 99 1.1× 98 1.4× 23 652
Carrow I. Wells United States 18 566 1.4× 187 1.7× 160 1.5× 132 1.4× 43 0.6× 46 843
Angela Hayes United Kingdom 15 484 1.2× 259 2.3× 73 0.7× 75 0.8× 61 0.9× 33 659
Kevin R. Kupcho United States 10 481 1.2× 104 0.9× 48 0.4× 80 0.9× 28 0.4× 22 707
Cyrille Kuhn United States 13 245 0.6× 128 1.1× 114 1.1× 135 1.5× 27 0.4× 15 456
Sailu Sarvagalla India 12 410 1.0× 136 1.2× 79 0.7× 36 0.4× 101 1.4× 15 576
André Richters Germany 17 480 1.2× 144 1.3× 57 0.5× 212 2.3× 111 1.6× 24 776
Jim Nonomiya United States 13 390 1.0× 127 1.1× 101 0.9× 127 1.4× 33 0.5× 18 659
Stephen M. Courtney United Kingdom 12 346 0.9× 95 0.8× 124 1.1× 215 2.3× 20 0.3× 15 572
Roberta Pireddu United States 10 465 1.2× 240 2.1× 95 0.9× 96 1.0× 44 0.6× 14 718

Countries citing papers authored by Rosemary Burke

Since Specialization
Citations

This map shows the geographic impact of Rosemary Burke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Burke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Burke more than expected).

Fields of papers citing papers by Rosemary Burke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Burke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Burke. The network helps show where Rosemary Burke may publish in the future.

Co-authorship network of co-authors of Rosemary Burke

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Burke. A scholar is included among the top collaborators of Rosemary Burke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Burke. Rosemary Burke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brennan, Sue, Gillinder Bedi, Rosemary Burke, et al.. (2025). Development of an Australian Clinical Practice Guideline on methylenedioxymethamphetamine (MDMA)-assisted Psychotherapy for Post-traumatic Stress Disorder. Journal of Affective Disorders. 391. 119866–119866.
2.
Ritzefeld, Markus, Zhangping Xiao, Sebastian A. Andrei, et al.. (2024). Design, Synthesis, and Evaluation of Inhibitors of Hedgehog Acyltransferase. Journal of Medicinal Chemistry. 67(2). 1061–1078. 3 indexed citations
3.
Liu, Manjuan, Amin Mirza, Craig McAndrew, et al.. (2023). Determination of Ligand-Binding Affinity (Kd) Using Transverse Relaxation Rate (R2) in the Ligand-Observed 1H NMR Experiment and Applications to Fragment-Based Drug Discovery. Journal of Medicinal Chemistry. 66(15). 10617–10627. 11 indexed citations
4.
Matthews, Thomas P., Tatiana McHardy, Giampiero Colombano, et al.. (2023). Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes. Journal of Medicinal Chemistry. 66(4). 2622–2645. 3 indexed citations
5.
Contreras, María F., Miguel A. Hermida, Kunal Shah, et al.. (2021). Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes. Cell Death and Disease. 12(11). 1075–1075. 4 indexed citations
6.
Acar, Ahmet, Daniel Nichol, Javier Fernández-Mateos, et al.. (2020). Exploiting evolutionary steering to induce collateral drug sensitivity in cancer. Nature Communications. 11(1). 1923–1923. 70 indexed citations
7.
Felisberto‐Rodrigues, Catarina, Craig McAndrew, Yann‐Vaï Le Bihan, et al.. (2019). Structural and functional characterisation of human RNA helicase DHX8 provides insights into the mechanism of RNA-stimulated ADP release. Biochemical Journal. 476(18). 2521–2543. 11 indexed citations
8.
Clarke, Paul A., Toby Roe, Steve Hobbs, et al.. (2019). Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer. Oncogene. 38(25). 5076–5090. 29 indexed citations
9.
Meyers, Joshua, N. Chessum, N. Yi Mok, et al.. (2018). Privileged Structures and Polypharmacology within and between Protein Families. ACS Medicinal Chemistry Letters. 9(12). 1199–1204. 12 indexed citations
10.
Chessum, N., Swee Y. Sharp, John Caldwell, et al.. (2017). Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766). Journal of Medicinal Chemistry. 61(3). 918–933. 74 indexed citations
11.
Lanyon‐Hogg, Thomas, Markus Ritzefeld, K. Boxall, et al.. (2017). Microfluidic Mobility Shift Assay for Real-Time Analysis of Peptide N-Palmitoylation. SLAS DISCOVERY. 22(4). 418–424. 11 indexed citations
12.
Lote, Hazel, Domenico Zito, Rosemary Burke, et al.. (2016). MicroRNAs as biomarkers of resistance to HER2 inhibitors in combination with chemotherapy in gastro-oesophageal cancer cell lines. Annals of Oncology. 27. vi549–vi549. 1 indexed citations
13.
Rodgers, Ursula R., Thomas Lanyon‐Hogg, Naoko Masumoto, et al.. (2016). Characterization of Hedgehog Acyltransferase Inhibitors Identifies a Small Molecule Probe for Hedgehog Signaling by Cancer Cells. ACS Chemical Biology. 11(12). 3256–3262. 37 indexed citations
14.
Jones, Alan M., Isaac M. Westwood, James Osborne, et al.. (2016). A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoforms. Scientific Reports. 6(1). 34701–34701. 25 indexed citations
15.
Gurden, Mark D., Isaac M. Westwood, Amir Faisal, et al.. (2015). Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. Cancer Research. 75(16). 3340–3354. 24 indexed citations
16.
Joshi, Amar, Yvette Newbatt, Craig McAndrew, et al.. (2015). Molecular mechanisms of human IRE1 activation through dimerization and ligand binding. Oncotarget. 6(15). 13019–13035. 42 indexed citations
17.
Bavetsias, Vassilios, Yolanda Pérez-Fuertes, Patrick J. McIntyre, et al.. (2015). 7-(Pyrazol-4-yl)-3H-imidazo[4,5-b]pyridine-based derivatives for kinase inhibition: Co-crystallisation studies with Aurora-A reveal distinct differences in the orientation of the pyrazole N1-substituent. Bioorganic & Medicinal Chemistry Letters. 25(19). 4203–4209. 13 indexed citations
18.
Cheeseman, Matthew D., Amir Faisal, Sydonia Rayter, et al.. (2014). Targeting the PPM1D phenotype; 2,4-bisarylthiazoles cause highly selective apoptosis in PPM1D amplified cell-lines. Bioorganic & Medicinal Chemistry Letters. 24(15). 3469–3474. 4 indexed citations
19.
Westwood, Isaac M., Kathy Boxall, Nathan Brown, et al.. (2013). Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2. PLoS ONE. 8(6). e65689–e65689. 12 indexed citations
20.
Newbatt, Yvette, Anthea Hardcastle, Craig McAndrew, et al.. (2012). Identification of Autophosphorylation Inhibitors of the Inositol-Requiring Enzyme 1 Alpha (IRE1α) by High-Throughput Screening Using a DELFIA Assay. SLAS DISCOVERY. 18(3). 298–308. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Ruddle Breakdown of academic impact, for papers by Carrow I. Wells Breakdown of academic impact, for papers by Angela Hayes Breakdown of academic impact, for papers by Kevin R. Kupcho Breakdown of academic impact, for papers by Cyrille Kuhn Breakdown of academic impact, for papers by Sailu Sarvagalla Breakdown of academic impact, for papers by André Richters Breakdown of academic impact, for papers by Jim Nonomiya Breakdown of academic impact, for papers by Stephen M. Courtney Breakdown of academic impact, for papers by Roberta Pireddu
Rankless by CCL
2026